The generic pharmaceuticals manufacturer has launched a corporate venturing subsidiary with an initial commitment of $30m.
Jordan-based generic pharmaceuticals producer Hikma Pharmaceuticals has announced a corporate venturing division dubbed Hikma Ventures and provided $30m in capital, Wamda reported yesterday.
The subsidiary was originally established in August 2015 but is only now set to close its first deals, which are expected to be complete within the next two months. The capital was entirely provided by Hikma, though the fund may be opened to external investors in future.
Hikma Ventures is targeting startups operating in the sectors of…
